newsfilter
← Latest News
Business Wire·

ChromaDex to Participate in the 17th Annual LD Micro Main Event

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announced that it will be participating at the 17th Annual LD Micro Main Event at